Type I IFN gene delivery suppresses regulatory T cells within tumors
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type I IFN gene delivery suppresses regulatory T cells within tumors
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 21, Issue 12, Pages 532-541
Publisher
Springer Nature
Online
2014-11-28
DOI
10.1038/cgt.2014.60
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF- Are Resistant to Th17 Conversion by IL-6
- (2014) S. G. Zheng et al. JOURNAL OF IMMUNOLOGY
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Genetic Engineering of Hematopoiesis for Targeted IFN- Delivery Inhibits Breast Cancer Progression
- (2014) G. Escobar et al. Science Translational Medicine
- Interferon- Suppresses cAMP to Disarm Human Regulatory T Cells
- (2013) N. Bacher et al. CANCER RESEARCH
- Complete Remission Achieved With Single Agent CNTO 328, an Anti–IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma
- (2013) Ajai Chari et al. Clinical Lymphoma Myeloma & Leukemia
- Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
- (2012) Joannes FM Jacobs et al. LANCET ONCOLOGY
- Targeting Regulatory T Cells in Cancer
- (2011) W. L. Byrne et al. CANCER RESEARCH
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
- (2011) M. S. Anglesio et al. CLINICAL CANCER RESEARCH
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- Syngeneic Hematopoietic Stem Cell Transplantation Enhances the Antitumor Immunity of Intratumoral Type I Interferon Gene Transfer for Sarcoma
- (2011) Takeshi Udagawa et al. HUMAN GENE THERAPY
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling
- (2011) L. Song et al. MOLECULAR CANCER THERAPEUTICS
- Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells
- (2011) Nicole Bacher et al. PLoS One
- Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
- (2010) Paola Rizza et al. AUTOIMMUNITY
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- Administration route-dependent induction of antitumor immunity by interferon-alpha gene transfer
- (2010) Kenta Narumi et al. CANCER SCIENCE
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer
- (2010) J. L. Gnerlich et al. JOURNAL OF IMMUNOLOGY
- APC Activation by IFN- Decreases Regulatory T Cell and Enhances Th Cell Functions
- (2010) L. Pace et al. JOURNAL OF IMMUNOLOGY
- Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
- (2009) M. D. Sharma et al. BLOOD
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Type I IFNs and their role in the development of autoimmune diseases
- (2009) Laura M Burdick et al. Expert Opinion On Drug Safety
- Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells
- (2009) Helena Cucak et al. IMMUNITY
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
- (2009) Natalia Martin-Orozco et al. IMMUNITY
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
- (2009) Lin Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
- (2008) Xuexian O. Yang et al. IMMUNITY
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
- (2008) Willscott E. Naugler et al. TRENDS IN MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started